
Vitract
Transforming mental health through the gut
Mississauga, Canada · Founded 2022 · $1.1M raised
- Headquarters
- Mississauga, Ontario
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2C
- Website
- vitract.com
- Total Funding
- $1.1M
- Last Round
- $1.1M SeedApr 2022
- Rounds
- 1
About
Vitract (Techstars NYC '22) is a health technology company that reverse chronic illnesses strongly tied to the gut microbiome, including digestive, metabolic, and mental illnesses. The company offers highly-personalized holistic treatment plans that address underlying causes rather than symptoms, using in-depth lab testing combined with personalized dietary and lifestyle recommendations. Vitract's approach is grounded in the premise that a healthy gut microbiome is the center of whole-body homeostasis, and it works to fix gut microbial imbalances to improve patient outcomes.
Summary
Vitract is a Sustainability company based in Mississauga, Canada, founded in 2022. It has raised $1.1M in total across 1 round, most recently a $1.1M Seed round in Apr 2022. Investors include Y Combinator Continuity Fund, Marathon Management Partners and Roosh Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
